Stefan Chin, MD
Gastroenterology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 33 years
- Columbia University College of Physicians and Surgeons, 1993
Offices
1 location · Genesis Healthcare Partners PC · 232 clinicians in this group
Hospitals listed: Ahmc Seton Medical Center · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chin’s office at (650) 756-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G83120 · Current
Licensed to practise in California · since 1996 · expires 2028-05-31 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Digestive Diagnostic Center, Inc.Ambulatory Surgery Center · Daly City, CA33.3% owner since 2003 · accredited by AAAHCAccreditation Renewed3 inspections, 1 with deficiencies · last 2017-09-26: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$118,542
Medicare paid this office $118,542 for 360 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 124 | $19,392 | $113 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $14,563 | $44 |
| Short return visit (20+ min) | 140 | $13,704 | $75 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $10,986 | $57 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $10,491 | $214 |
See all 14 services
| Return visit (30+ min) | 124 | $19,392 | $113 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $14,563 | $44 |
| Short return visit (20+ min) | 140 | $13,704 | $75 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $10,986 | $57 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $10,491 | $214 |
| Biopsy of large bowel using a flexible endoscope | 87 | $9,015 | $102 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $6,134 | $106 |
| New patient visit (45+ min) | 43 | $6,117 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,379 | $68 |
| New patient visit (30+ min) | 32 | $2,755 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,607 | $137 |
| Ultrasound scan of organ tissue for measuring elasticity | 22 | $2,306 | $105 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 75 | $1,306 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 25 | $149 | $5 |
Procedures Medicare counted
| Colonoscopy | 138 | More than 87% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 67 | More than 69% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 81 | 74 | 87 | 84 | 60 | 88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | 63 | 67 | 58 | 55 | 58 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | 46 | 60 | 67 | 53 | 49 |
| Diagnostic exam of large bowel using a flexible endoscope | – | – | – | 14 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
360 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 14% · Women 51% · Also on Medicaid 20% · Health risk score 1.43. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 31% · Chronic kidney disease 28% · Atrial fibrillation 22% · Cancer 18% · Heart failure 17% · Depression 15% · COPD 11% · Stroke 9% · Dementia 8%.
The office billed $696,785, Medicare allowed $157,132 and paid $118,542; for 1,493 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 360 | 1,493 | 75 | 1.43 | $696,785 | $118,542 |
| 2023 | 344 | 1,388 | 75 | 1.19 | $642,281 | $112,898 |
| 2022 | 393 | 1,467 | 74 | 1.23 | $512,593 | $123,390 |
| 2021 | 392 | 1,611 | 74 | 1.30 | $396,873 | $128,260 |
| 2020 | 329 | 873 | 75 | 1.47 | $266,980 | $78,987 |
| 2019 | 405 | 1,086 | 75 | 1.52 | $265,474 | $100,040 |
| 2018 | 442 | 1,334 | 75 | 1.63 | $284,204 | $104,554 |
| 2017 | 472 | 1,574 | 75 | 1.70 | $355,568 | $135,970 |
| 2016 | 498 | 1,335 | 76 | 1.84 | $342,221 | $133,820 |
| 2015 | 510 | 1,354 | 76 | 1.82 | $313,648 | $121,267 |
| 2014 | 577 | 1,665 | 74 | 1.74 | $447,306 | $151,462 |
| 2013 | 634 | 1,895 | 76 | 1.79 | $537,759 | $185,539 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 124 | $17,985 | $104 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 26 | $14,058 | $44 |
| Short return visit (20+ min) | 145 | $13,533 | $80 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $11,503 | $217 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 26 | $10,370 | $55 |
| New patient visit (45+ min) | 56 | $7,538 | $135 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | $4,912 | $89 |
| Biopsy of large bowel using a flexible endoscope | 59 | $4,558 | $76 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,260 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,414 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,152 | $135 |
| New patient visit (30+ min) | 13 | $1,155 | $89 |
| Measurement of liver stiffness | 22 | $639 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 29 | $119 | $4 |
2022: 16 services
| Return visit (30+ min) | 158 | $23,666 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $13,727 | $205 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 26 | $13,511 | $43 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 27 | $10,816 | $55 |
| New patient visit (45+ min) | 62 | $7,469 | $120 |
| Short return visit (20+ min) | 84 | $6,704 | $71 |
| Biopsy of large bowel using a flexible endoscope | 84 | $6,283 | $75 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $5,038 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $5,023 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,211 | $162 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,076 | $205 |
| Long return visit (40+ min) | 14 | $2,320 | $166 |
| New patient visit (30+ min) | 24 | $2,064 | $86 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $1,994 | $142 |
| Measurement of liver stiffness | 18 | $468 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 35 | $167 | $5 |
2021: 16 services
| Return visit (30+ min) | 143 | $20,872 | $110 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | $12,876 | $215 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 31 | $12,160 | $35 |
| Short return visit (20+ min) | 129 | $11,701 | $71 |
| New patient visit (45+ min) | 68 | $8,821 | $130 |
| Biopsy of large bowel using a flexible endoscope | 86 | $8,525 | $98 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 31 | $8,241 | $38 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $6,614 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,816 | $64 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 12 | $3,598 | $67 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,558 | $209 |
| Long return visit (40+ min) | 16 | $3,039 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,788 | $174 |
| New patient visit (30+ min) | 28 | $2,268 | $81 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 11 | $202 | $18 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 40 | $194 | $5 |
2020: 12 services
| Return visit (30+ min) | 113 | $12,875 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 46 | $9,964 | $217 |
| Short return visit (20+ min) | 116 | $9,907 | $63 |
| New patient visit (45+ min) | 58 | $7,056 | $122 |
| Biopsy of large bowel using a flexible endoscope | 74 | $6,872 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $6,721 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,549 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,389 | $183 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,799 | $35 |
| New patient visit (30+ min) | 19 | $1,662 | $87 |
| Measurement of liver stiffness | 14 | $494 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 38 | $201 | $5 |
2019: 15 services
| Return visit (30+ min) | 116 | $13,371 | $92 |
| Short return visit (20+ min) | 153 | $11,112 | $56 |
| Biopsy of large bowel using a flexible endoscope | 80 | $10,081 | $124 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $7,354 | $110 |
| New patient visit (45+ min) | 53 | $6,346 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,148 | $176 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $5,651 | $209 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 52 | $3,397 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,852 | $65 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,426 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $1,760 | $88 |
| Long return visit (40+ min) | 12 | $1,628 | $136 |
| New patient visit (30+ min) | 18 | $1,443 | $80 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 150 | $754 | $5 |
| Measurement of liver stiffness | 17 | $663 | $39 |
2018: 16 services
| Short return visit (20+ min) | 183 | $14,305 | $58 |
| Biopsy of large bowel using a flexible endoscope | 92 | $11,506 | $121 |
| Return visit (30+ min) | 106 | $11,447 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $9,450 | $107 |
| New patient visit (45+ min) | 63 | $8,538 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,994 | $174 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $7,643 | $201 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 80 | $6,750 | $33 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,367 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,328 | $63 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,913 | $106 |
| New patient visit (30+ min) | 22 | $1,795 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,297 | $93 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 184 | $947 | $5 |
| Measurement of liver stiffness | 12 | $483 | $40 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 20 | $226 | $11 |
2017: 16 services
| Short return visit (20+ min) | 179 | $13,724 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $13,214 | $169 |
| Return visit (30+ min) | 116 | $12,812 | $92 |
| Biopsy of large bowel using a flexible endoscope | 106 | $12,787 | $120 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 105 | $12,491 | $34 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $10,698 | $218 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $9,328 | $106 |
| New patient visit (45+ min) | 71 | $9,238 | $130 |
| Critical care, first 30-74 minutes | 14 | $7,419 | $195 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,543 | $206 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,369 | $169 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,985 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,804 | $64 |
| New patient visit (30+ min) | 17 | $1,403 | $83 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 187 | $957 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $141 | $11 |
2016: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $17,435 | $180 |
| Short return visit (20+ min) | 205 | $16,896 | $62 |
| Return visit (30+ min) | 111 | $11,909 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 115 | $11,534 | $34 |
| New patient visit (45+ min) | 74 | $10,100 | $136 |
| Biopsy of large bowel using a flexible endoscope | 74 | $9,688 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 75 | $9,017 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $7,580 | $230 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,218 | $169 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,288 | $208 |
| Incision of pancreatic outlet using a flexible endoscope | 15 | $1,988 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,866 | $64 |
| New patient visit (30+ min) | 18 | $1,462 | $81 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,420 | $118 |
2015: 14 services
| Short return visit (20+ min) | 215 | $19,557 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 139 | $15,133 | $34 |
| Biopsy of large bowel using a flexible endoscope | 68 | $12,129 | $176 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $11,948 | $178 |
| Return visit (30+ min) | 96 | $10,055 | $92 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $8,319 | $260 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 61 | $7,761 | $121 |
| New patient visit (45+ min) | 46 | $6,434 | $140 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $3,310 | $184 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $3,199 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,747 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,675 | $62 |
| New patient visit (30+ min) | 16 | $1,531 | $96 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,309 | $109 |
2014: 15 services
| Short return visit (20+ min) | 286 | $27,592 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 165 | $17,063 | $34 |
| Biopsy of large bowel using a flexible endoscope | 88 | $14,953 | $166 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | $10,620 | $128 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $9,935 | $237 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,722 | $177 |
| New patient visit (45+ min) | 72 | $9,143 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $5,120 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $4,345 | $241 |
| Return visit (30+ min) | 46 | $3,991 | $83 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $3,177 | $177 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,896 | $241 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,692 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,112 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,093 | $62 |
2013: 19 services
| Short return visit (20+ min) | 286 | $29,057 | $60 |
| Biopsy of large bowel using a flexible endoscope | 109 | $21,342 | $194 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 177 | $19,031 | $34 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $14,236 | $147 |
| Removal of external hemorrhoids by rubber banding | 20 | $14,033 | $265 |
| New patient visit (45+ min) | 85 | $11,231 | $132 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 34 | $8,002 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,004 | $163 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 12 | $5,733 | $441 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $5,494 | $85 |
| Return visit (30+ min) | 58 | $5,486 | $91 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $4,362 | $190 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,650 | $243 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,564 | $119 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,916 | $243 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,902 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,623 | $62 |
| Critical care, first 30-74 minutes | 11 | $2,292 | $191 |
| Incision of pancreatic outlet using a flexible endoscope | 12 | $1,238 | $95 |
Medicaid work
$183 in 2024
Medicaid paid $183 for 15 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $183 |
| 2024 | 15 | 1 | 14 | $183 |
| 2023 | 99 | 4 | 17 | $1,307 |
| 2022 | 73 | 1 | 18 | $1,259 |
| 2021 | 40 | 1 | 15 | $708 |
| 2020 | 25 | 2 | 13 | $373 |
| 2019 | 43 | 2 | 15 | $440 |
| 2018 | 118 | 3 | 21 | $1,920 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 47 | $1,149 |
| Short return visit (20+ min) | 15 | $131 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 25 | $28 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $0 |
2022
| Return visit (30+ min) | 73 | $1,259 |
2021
| Return visit (30+ min) | 40 | $708 |
2020
| Short return visit (20+ min) | 13 | $256 |
| Return visit (30+ min) | 12 | $117 |
2019
| Short return visit (20+ min) | 29 | $400 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 14 | $40 |
2018
| Short return visit (20+ min) | 67 | $1,473 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 35 | $434 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 16 | $12 |
Drugs they prescribed that Part D paid
$887,311
Pharmacies billed $887,311 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,787) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,365 generic and fewer than 11 brand-name prescriptions · $887,311 in drug cost · 44 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 34 | $284,644 | $8,372 |
| Zenpep | 18 | $109,977 | $6,110 |
| Vemlidy | 36 | $86,870 | $2,413 |
| Linzess | 58 | $65,928 | $1,137 |
| Dexlansoprazole Dr | 60 | $20,535 | $342 |
See all 28 drugs
| Creon | 34 | $284,644 | $8,372 |
| Zenpep | 18 | $109,977 | $6,110 |
| Vemlidy | 36 | $86,870 | $2,413 |
| Linzess | 58 | $65,928 | $1,137 |
| Dexlansoprazole Dr | 60 | $20,535 | $342 |
| Pantoprazole | 658 | $18,820 | $29 |
| Mesalamine | 20 | $18,535 | $927 |
| Motegrity | 24 | $18,105 | $754 |
| Plenvu | 105 | $14,687 | $140 |
| Lubiprostone | 62 | $9,006 | $145 |
| Famotidine | 136 | $5,197 | $38 |
| Ursodiol | 18 | $4,439 | $247 |
| Omeprazole | 104 | $2,816 | $27 |
| Mercaptopurine | 18 | $1,984 | $110 |
| Sod Sulf-Potass Sulf-Mag Sulf | 23 | $1,712 | $74 |
| Colestipol | 22 | $1,653 | $75 |
| Suflave | 12 | $1,463 | $122 |
| Rabeprazole | 18 | $1,193 | $66 |
| Esomeprazole Magnesium | 27 | $949 | $35 |
| Lansoprazole | 13 | $935 | $72 |
| Sucralfate | 14 | $679 | $48 |
| Lactulose | 22 | $645 | $29 |
| Dicyclomine | 34 | $493 | $15 |
| Gavilyte-C | 23 | $440 | $19 |
| Prednisone | 19 | $382 | $20 |
| Clarithromycin | 12 | $295 | $25 |
| Hydrocortisone | 17 | $176 | $10 |
| Amoxicillin | 12 | $53 | $4 |
Year by year
| 2024 | 1,787 | 550 | 0% (0) | None | $887,311 |
| 2023 | 1,496 | 518 | 0% (0) | 25% | $661,693 |
| 2022 | 1,310 | 405 | 0% (0) | None | $719,209 |
| 2021 | 1,230 | 386 | 0% (0) | 33% | $588,130 |
| 2020 | 1,091 | 303 | 0% (0) | 32% | $547,817 |
| 2019 | 1,100 | 365 | 0% (0) | None | $608,366 |
| 2018 | 1,271 | 419 | None | None | $875,666 |
| 2017 | 1,456 | 461 | None | 41% | $1,237,135 |
| 2016 | 1,431 | 395 | 0% (0) | 40% | $1,980,303 |
| 2015 | 1,328 | 343 | None | 41% | $1,155,331 |
| 2014 | 1,381 | 336 | 0% (0) | 43% | $745,537 |
| 2013 | 1,354 | 335 | 0% (0) | None | $361,797 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Creon | 39 | $208,692 | $5,351 |
| Linzess | 64 | $74,970 | $1,171 |
| Vemlidy | 22 | $59,603 | $2,709 |
| Dexlansoprazole Dr | 50 | $24,422 | $488 |
| Mesalamine | 23 | $23,661 | $1,029 |
| Lubiprostone | 46 | $17,714 | $385 |
| Pantoprazole | 563 | $16,841 | $30 |
| Plenvu | 105 | $15,304 | $146 |
| Motegrity | 15 | $11,756 | $784 |
| Dexilant | 12 | $8,282 | $690 |
| Emtricitabine-Tenofovir Disop | 12 | $5,043 | $420 |
| Ursodiol | 15 | $4,964 | $331 |
| Famotidine | 100 | $3,101 | $31 |
| Omeprazole | 107 | $2,940 | $27 |
| Sod Sulf-Potass Sulf-Mag Sulf | 28 | $2,339 | $84 |
| Colestipol | 17 | $1,675 | $99 |
| Gavilyte-C | 41 | $882 | $22 |
| Lactulose | 16 | $743 | $46 |
| Dicyclomine | 15 | $417 | $28 |
| Hydrocortisone | 13 | $137 | $11 |
2022: 21 drugs
| Creon | 43 | $282,527 | $6,570 |
| Vemlidy | 25 | $67,139 | $2,686 |
| Linzess | 63 | $66,344 | $1,053 |
| Xifaxan | 11 | $45,423 | $4,129 |
| Mesalamine | 21 | $24,745 | $1,178 |
| Dexilant | 34 | $22,935 | $675 |
| Lubiprostone | 43 | $19,900 | $463 |
| Motegrity | 18 | $13,688 | $760 |
| Pantoprazole | 471 | $13,392 | $28 |
| Plenvu | 79 | $10,737 | $136 |
| Dexlansoprazole Dr | 16 | $9,633 | $602 |
| Esomeprazole Magnesium | 11 | $3,977 | $362 |
| Omeprazole | 101 | $2,635 | $26 |
| Lansoprazole | 12 | $2,549 | $212 |
| Colestipol | 23 | $1,884 | $82 |
| Famotidine | 70 | $1,816 | $26 |
| Gavilyte-C | 26 | $487 | $19 |
| Emtricitabine-Tenofovir Disop | 12 | $436 | $36 |
| Dicyclomine | 16 | $387 | $24 |
| Hydrocortisone | 23 | $314 | $14 |
| Lactulose | 15 | $285 | $19 |
2021: 21 drugs
| Creon | 60 | $277,087 | $4,618 |
| Vemlidy | 24 | $50,850 | $2,119 |
| Linzess | 47 | $49,671 | $1,057 |
| Xifaxan | 15 | $37,566 | $2,504 |
| Dexilant | 38 | $28,254 | $744 |
| Lubiprostone | 37 | $17,508 | $473 |
| Mesalamine | 15 | $16,745 | $1,116 |
| Pantoprazole | 436 | $11,559 | $27 |
| Motegrity | 21 | $10,063 | $479 |
| Plenvu | 79 | $10,051 | $127 |
| Emtricitabine-Tenofovir Disop | 12 | $5,200 | $433 |
| Suprep | 38 | $4,381 | $115 |
| Omeprazole | 102 | $3,037 | $30 |
| Famotidine | 56 | $1,848 | $33 |
| Esomeprazole Magnesium | 19 | $1,163 | $61 |
| Hydrocortisone | 20 | $463 | $23 |
| Clarithromycin | 14 | $332 | $24 |
| Lactulose | 15 | $308 | $21 |
| Dicyclomine | 18 | $302 | $17 |
| Gavilyte-C | 12 | $177 | $15 |
| Amoxicillin | 15 | $100 | $7 |
2020: 19 drugs
| Creon | 61 | $240,160 | $3,937 |
| Vemlidy | 22 | $44,660 | $2,030 |
| Linzess | 44 | $41,329 | $939 |
| Xifaxan | 18 | $40,771 | $2,265 |
| Dexilant | 45 | $32,074 | $713 |
| Amitiza | 39 | $25,975 | $666 |
| Mesalamine | 32 | $20,683 | $646 |
| Pantoprazole | 345 | $9,427 | $27 |
| Balsalazide Disodium | 15 | $6,643 | $443 |
| Budesonide Ec | 14 | $6,444 | $460 |
| Plenvu | 39 | $4,612 | $118 |
| Famotidine | 42 | $2,532 | $60 |
| Suprep | 24 | $2,505 | $104 |
| Omeprazole | 112 | $2,341 | $21 |
| Esomeprazole Magnesium | 28 | $1,824 | $65 |
| Entecavir | 16 | $651 | $41 |
| Lactulose | 17 | $479 | $28 |
| Hydrocortisone | 14 | $232 | $17 |
| Gavilyte-C | 14 | $208 | $15 |
2019: 19 drugs
| Creon | 45 | $154,566 | $3,435 |
| Vemlidy | 38 | $61,228 | $1,611 |
| Linzess | 58 | $41,432 | $714 |
| Dexilant | 49 | $38,441 | $785 |
| Xifaxan | 12 | $32,105 | $2,675 |
| Mesalamine | 29 | $24,964 | $861 |
| Truvada | 11 | $19,236 | $1,749 |
| Amitiza | 30 | $16,541 | $551 |
| Suprep | 91 | $9,076 | $100 |
| Trulance | 12 | $6,706 | $559 |
| Pantoprazole | 269 | $5,581 | $21 |
| Omeprazole | 119 | $2,260 | $19 |
| Entecavir | 12 | $1,803 | $150 |
| Esomeprazole Magnesium | 21 | $1,062 | $51 |
| Famotidine | 35 | $958 | $27 |
| Colyte With Flavor Packets | 13 | $766 | $59 |
| Lactulose | 20 | $675 | $34 |
| Gavilyte-C | 20 | $251 | $13 |
| Hydrocortisone | 14 | $50 | $4 |
2018: 22 drugs
| Creon | 68 | $250,471 | $3,683 |
| Xifaxan | 28 | $63,791 | $2,278 |
| Vemlidy | 45 | $54,146 | $1,203 |
| Linzess | 37 | $33,621 | $909 |
| Dexilant | 43 | $28,644 | $666 |
| Viread | 15 | $25,178 | $1,679 |
| Mesalamine | 13 | $17,209 | $1,324 |
| Entecavir | 20 | $16,913 | $846 |
| Amitiza | 30 | $16,143 | $538 |
| Budesonide Ec | 11 | $12,599 | $1,145 |
| Suprep | 124 | $11,897 | $96 |
| Nexium | 14 | $7,605 | $543 |
| Pantoprazole | 258 | $7,172 | $28 |
| Polyethylene Glycol 3350 | 84 | $6,012 | $72 |
| Balsalazide Disodium | 12 | $3,868 | $322 |
| Omeprazole | 144 | $3,853 | $27 |
| Esomeprazole Magnesium | 17 | $3,085 | $181 |
| Moviprep | 26 | $2,516 | $97 |
| Lansoprazole | 11 | $1,301 | $118 |
| Famotidine | 33 | $889 | $27 |
| Lactulose | 16 | $536 | $34 |
| Gavilyte-C | 23 | $233 | $10 |
2017: 23 drugs
| Creon | 111 | $366,046 | $3,298 |
| Harvoni | 11 | $354,609 | $32,237 |
| Xifaxan | 25 | $50,966 | $2,039 |
| Linzess | 60 | $39,479 | $658 |
| Viread | 16 | $33,793 | $2,112 |
| Vemlidy | 24 | $29,787 | $1,241 |
| Lialda | 23 | $29,147 | $1,267 |
| Dexilant | 43 | $28,826 | $670 |
| Amitiza | 31 | $16,900 | $545 |
| Delzicol | 12 | $14,125 | $1,177 |
| Nexium | 22 | $12,390 | $563 |
| Vancomycin | 21 | $12,112 | $577 |
| Suprep | 134 | $11,881 | $89 |
| Polyethylene Glycol 3350 | 93 | $8,742 | $94 |
| Pantoprazole | 280 | $7,926 | $28 |
| Esomeprazole Magnesium | 21 | $6,748 | $321 |
| Omeprazole | 172 | $4,706 | $27 |
| Colyte With Flavor Packets | 30 | $1,642 | $55 |
| Moviprep | 16 | $1,590 | $99 |
| Lansoprazole | 13 | $1,450 | $112 |
| Famotidine | 47 | $940 | $20 |
| Lactulose | 12 | $376 | $31 |
| Gavilyte-C | 29 | $269 | $9 |
2016: 27 drugs
| Harvoni | 13 | $412,275 | $31,713 |
| Creon | 128 | $384,808 | $3,006 |
| Sovaldi | 12 | $341,296 | $28,441 |
| Daklinza | 12 | $256,351 | $21,363 |
| Xifaxan | 21 | $48,937 | $2,330 |
| Viread | 24 | $46,327 | $1,930 |
| Lialda | 35 | $39,486 | $1,128 |
| Linzess | 43 | $32,616 | $759 |
| Vancomycin | 24 | $21,864 | $911 |
| Nexium | 29 | $19,288 | $665 |
| Dexilant | 31 | $19,234 | $620 |
| Amitiza | 37 | $17,991 | $486 |
| Delzicol | 12 | $13,012 | $1,084 |
| Ursodiol | 27 | $11,996 | $444 |
| Polyethylene Glycol 3350 | 119 | $9,907 | $83 |
| Esomeprazole Magnesium | 16 | $6,781 | $424 |
| Suprep | 76 | $6,250 | $82 |
| Pantoprazole | 254 | $5,481 | $22 |
| Omeprazole | 171 | $3,298 | $19 |
| Balsalazide Disodium | 13 | $3,208 | $247 |
| Proctozone-Hc | 12 | $712 | $59 |
| Lactulose | 17 | $685 | $40 |
| Famotidine | 36 | $681 | $19 |
| Diphenoxylate-Atropine | 17 | $669 | $39 |
| Metoclopramide | 13 | $208 | $16 |
| Peg 3350-Electrolyte | 17 | $171 | $10 |
| Gavilyte-C | 13 | $152 | $12 |
2015: 25 drugs
| Creon | 118 | $263,375 | $2,232 |
| Xifaxan | 28 | $59,039 | $2,109 |
| Zenpep | 12 | $42,968 | $3,581 |
| Viread | 18 | $36,741 | $2,041 |
| Dexilant | 50 | $23,983 | $480 |
| Nexium | 37 | $22,831 | $617 |
| Linzess | 40 | $22,642 | $566 |
| Vancomycin | 19 | $19,331 | $1,017 |
| Lialda | 15 | $18,353 | $1,224 |
| Amitiza | 42 | $17,563 | $418 |
| Ursodiol | 38 | $12,073 | $318 |
| Delzicol | 12 | $11,838 | $987 |
| Polyethylene Glycol 3350 | 111 | $7,794 | $70 |
| Pantoprazole | 236 | $4,868 | $21 |
| Apriso | 12 | $4,675 | $390 |
| Suprep | 46 | $3,815 | $83 |
| Omeprazole | 178 | $3,167 | $18 |
| Proctozone-Hc | 17 | $731 | $43 |
| Mercaptopurine | 12 | $710 | $59 |
| Diphenoxylate-Atropine | 12 | $626 | $52 |
| Lactulose | 15 | $580 | $39 |
| Famotidine | 28 | $362 | $13 |
| Metoclopramide | 13 | $158 | $12 |
| Prednisone | 12 | $140 | $12 |
| Peg 3350-Electrolyte | 14 | $139 | $10 |
2014: 24 drugs
| Creon | 112 | $178,495 | $1,594 |
| Viread | 31 | $46,123 | $1,488 |
| Baraclude | 26 | $36,581 | $1,407 |
| Nexium | 44 | $27,129 | $617 |
| Xifaxan | 17 | $24,024 | $1,413 |
| Vancomycin | 17 | $22,836 | $1,343 |
| Dexilant | 64 | $18,419 | $288 |
| Amitiza | 30 | $10,148 | $338 |
| Linzess | 30 | $8,500 | $283 |
| Prilosec | 12 | $7,525 | $627 |
| Pantoprazole | 215 | $7,212 | $34 |
| Polyethylene Glycol 3350 | 137 | $6,403 | $47 |
| Ursodiol | 31 | $5,777 | $186 |
| Omeprazole | 216 | $5,291 | $24 |
| Suprep | 58 | $4,613 | $80 |
| Apriso | 12 | $4,031 | $336 |
| Balsalazide Disodium | 17 | $2,372 | $140 |
| Lansoprazole | 18 | $929 | $52 |
| Generlac | 11 | $538 | $49 |
| Peg 3350-Electrolyte | 29 | $316 | $11 |
| Proctozone-Hc | 13 | $180 | $14 |
| Famotidine | 11 | $95 | $9 |
| Metoclopramide | 13 | $91 | $7 |
| Dicyclomine | 11 | $83 | $8 |
2013: 22 drugs
| Creon | 95 | $116,075 | $1,222 |
| Viread | 40 | $36,031 | $901 |
| Baraclude | 25 | $34,074 | $1,363 |
| Nexium | 59 | $25,924 | $439 |
| Xifaxan | 15 | $20,771 | $1,385 |
| Vancomycin | 12 | $13,213 | $1,101 |
| Dexilant | 67 | $12,934 | $193 |
| Aciphex | 17 | $9,085 | $534 |
| Prilosec | 13 | $7,623 | $586 |
| Polyethylene Glycol 3350 | 151 | $6,523 | $43 |
| Omeprazole | 264 | $5,174 | $20 |
| Amitiza | 18 | $4,875 | $271 |
| Pantoprazole | 217 | $4,234 | $20 |
| Ursodiol | 34 | $3,783 | $111 |
| Apriso | 12 | $3,752 | $313 |
| Suprep | 26 | $1,889 | $73 |
| Moviprep | 13 | $915 | $70 |
| Famotidine | 52 | $380 | $7 |
| Peg-3350 With Flavor Packs | 16 | $357 | $22 |
| Peg 3350-Electrolyte | 25 | $303 | $12 |
| Metoclopramide | 19 | $121 | $6 |
| Dicyclomine | 16 | $105 | $7 |
Money from drug and device companies
$1,944 in 2025
| 2025 | 13 | 83 | None | $1,944 |
| 2024 | 15 | 77 | None | $1,610 |
| 2023 | 16 | 86 | None | $1,864 |
| 2022 | 13 | 120 | None | $2,255 |
| 2021 | 13 | 156 | None | $2,715 |
| 2020 | 11 | 93 | None | $1,631 |
| 2019 | 18 | 114 | None | $1,827 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Creon | $510 | 26 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $480 | 18 payments
|
| Aimmune Therapeutics | Zenpep | $208 | 7 payments
|
| Janssen Biotech | Tremfya | $207 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $140 | 6 payments
|
| Ardelyx | Ibsrela | $140 | 8 payments
|
See all 83 published payments
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-19 | Entyvio | $23 |
| Gilead Sciences | Meals · 2025-12-18 | None | $32 |
| Abbvie | Meals · 2025-12-13 | Creon | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-12-10 | Rezdiffra | $36 |
| Abbvie | Meals · 2025-12-09 | Creon | $21 |
| Ardelyx | Meals · 2025-12-05 | Ibsrela | $8 |
| Madrigal Pharmaceuticals | Meals · 2025-12-05 | Rezdiffra | $21 |
| Aimmune Therapeutics | Meals · 2025-12-03 | Zenpep | $28 |
| Abbvie | Meals · 2025-11-24 | Linzess | $13 |
| Janssen Biotech | Meals · 2025-11-19 | Tremfya | $31 |
| Abbvie | Meals · 2025-11-18 | Linzess | $15 |
| Aimmune Therapeutics | Meals · 2025-11-18 | Zenpep | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-14 | Entyvio | $25 |
| Abbvie | Meals · 2025-11-10 | Linzess | $29 |
| Abbvie | Meals · 2025-11-04 | Linzess | $15 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-04 | Xifaxan | $15 |
| Abbvie | Meals · 2025-10-31 | Linzess | $13 |
| Alnylam Pharmaceuticals | Meals · 2025-10-17 | Givlaari | $36 |
| Ardelyx | Meals · 2025-10-17 | Ibsrela | $11 |
| Madrigal Pharmaceuticals | Meals · 2025-10-16 | Rezdiffra | $48 |
| Aimmune Therapeutics | Meals · 2025-10-13 | Zenpep | $34 |
| Abbvie | Meals · 2025-10-10 | Creon | $18 |
| Madrigal Pharmaceuticals | Meals · 2025-10-08 | Rezdiffra | $17 |
| Abbvie | Meals · 2025-10-01 | Linzess | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-24 | Entyvio | $24 |
| Aimmune Therapeutics | Meals · 2025-09-19 | Zenpep | $34 |
| Abbvie | Meals · 2025-09-17 | Linzess | $29 |
| Abbvie | Meals · 2025-09-12 | Creon | $27 |
| Ardelyx | Meals · 2025-09-12 | Ibsrela | $18 |
| Abbvie | Meals · 2025-09-03 | Linzess | $10 |
| Madrigal Pharmaceuticals | Meals · 2025-08-27 | Rezdiffra | $46 |
| Janssen Biotech | Meals · 2025-08-20 | Tremfya | $16 |
| Gilead Sciences | Meals · 2025-08-20 | None | $30 |
| Abbvie | Meals · 2025-08-19 | Linzess | $32 |
| Janssen Biotech | Meals · 2025-08-15 | Tremfya | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-08-14 | Rezdiffra | $9 |
| Abbvie | Meals · 2025-08-13 | Creon | $30 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-08 | Entyvio | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-08-07 | Rezdiffra | $33 |
| Ardelyx | Meals · 2025-07-31 | Ibsrela | $16 |
| Abbvie | Meals · 2025-07-17 | Creon | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-07-10 | Rezdiffra | $33 |
| Ardelyx | Meals · 2025-06-25 | Ibsrela | $19 |
| Aimmune Therapeutics | Meals · 2025-06-24 | Zenpep | $35 |
| Abbvie | Meals · 2025-06-19 | Creon | $18 |
| Madrigal Pharmaceuticals | Meals · 2025-06-13 | Rezdiffra | $35 |
| Celltrion USA | Meals · 2025-06-07 | Vegzelma | $27 |
| Abbvie | Meals · 2025-06-05 | Linzess | $13 |
| Ardelyx | Meals · 2025-06-03 | Ibsrela | $10 |
| Madrigal Pharmaceuticals | Meals · 2025-05-23 | Rezdiffra | $35 |
| Ardelyx | Meals · 2025-05-13 | Ibsrela | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-12 | Entyvio | $28 |
| Abbvie | Meals · 2025-05-07 | Linzess | $26 |
| Abbvie | Meals · 2025-05-01 | Creon | $26 |
| Janssen Biotech | Meals · 2025-04-18 | Tremfya | $28 |
| Lilly USA | Meals · 2025-04-16 | Omvoh | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-04-11 | Rezdiffra | $39 |
| Abbvie | Meals · 2025-04-09 | Creon | $24 |
| Abbvie | Meals · 2025-04-01 | Creon | $15 |
| Ardelyx | Meals · 2025-03-25 | Ibsrela | $27 |
| Aimmune Therapeutics | Meals · 2025-03-25 | Zenpep | $11 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-18 | Entyvio | $13 |
| Abbvie | Meals · 2025-03-06 | Creon | $31 |
| Janssen Biotech | Meals · 2025-02-28 | Tremfya | $28 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-02-27 | Rezdiffra | $20 |
| Braintree Laboratories | Meals · 2025-02-26 | Sutab | $20 |
| Abbvie | Meals · 2025-02-20 | Creon | $10 |
| Abbvie | Meals · 2025-02-15 | Creon | $15 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-02-12 | Rezdiffra | $11 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-11 | Relistor | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-02-07 | Rezdiffra | $35 |
| Aimmune Therapeutics | Meals · 2025-02-07 | Vowst | $37 |
| Abbvie | Meals · 2025-02-05 | Creon | $9 |
| Janssen Biotech | Meals · 2025-01-31 | Tremfya | $35 |
| Madrigal Pharmaceuticals | Meals · 2025-01-30 | Rezdiffra | $3 |
| Madrigal Pharmaceuticals | Meals · 2025-01-30 | Rezdiffra | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-01-29 | Rezdiffra | $2 |
| Ironwood Pharmaceuticals | Meals · 2025-01-22 | Linzess | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-01-18 | Rezdiffra | $35 |
| Abbvie | Meals · 2025-01-17 | Linzess | $11 |
| Janssen Biotech | Meals · 2025-01-07 | Tremfya | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,610
| Abbvie | Creon | $359 | 17 payments
|
| Janssen Biotech | Stelara | $359 | 17 payments
|
| Ironwood Pharmaceuticals | Linzess | $141 | 9 payments
|
| Celltrion USA | Vegzelma | $140 | 10 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $113 | 5 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $102 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $85 | 4 payments
|
| Gilead Sciences | None | $84 | 3 payments
|
| Phathom Pharmaceuticals | Voquezna | $60 | 2 payments
|
| Aimmune Therapeutics | Zenpep | $43 | 2 payments
|
| Lilly USA | Omvoh | $34 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $29 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $21 | 1 payment
|
| Ipsen Biopharmaceuticals | None | $21 | 1 payment
|
| Braintree Laboratories | Suflave | $18 | 1 payment
|
2023: $1,864
| AbbVie | Linzess | $559 | 30 payments
|
| Gilead Sciences | None | $261 | 9 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $222 | 11 payments
|
| Janssen Biotech | Remicade | $146 | 8 payments
|
| Ironwood Pharmaceuticals | Linzess | $97 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $92 | 4 payments
|
| Braintree Laboratories | Sutab | $77 | 3 payments
|
| Nestle Healthcare Nutrition | Zenpep | $75 | 3 payments
|
| Mauna Kea Technologies | None | $65 | 1 payment
|
| QOL Medical | Sucraid | $56 | 2 payments
|
| Celltrion USA | Yuflyma | $53 | 3 payments
|
| Intercept Pharmaceuticals | Ocaliva | $53 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $37 | 1 payment
|
| RedHill Biopharma | Talicia | $32 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
| Ardelyx | Ibsrela | $18 | 1 payment
|
2022: $2,255
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $1,018 | 56 payments
|
| Abbvie | Creon | $349 | 21 payments
|
| Janssen Biotech | Remicade | $195 | 12 payments
|
| Gilead Sciences | None | $132 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $125 | 5 payments
|
| Nestle HealthCare Nutrition | Zenpep | $123 | 4 payments
|
| Ironwood Pharmaceuticals | Linzess | $88 | 5 payments
|
| Ardelyx | Ibsrela | $74 | 3 payments
|
| RedHill Biopharma | Talicia | $47 | 2 payments
|
| Daiichi Sankyo | Injectafer | $46 | 2 payments
|
| Celgene | Zeposia | $21 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $20 | 1 payment
|
| Braintree Laboratories | Sutab | $17 | 1 payment
|
2021: $2,715
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $819 | 51 payments
|
| AbbVie | Humira | $665 | 33 payments
|
| Gilead Sciences | None | $410 | 26 payments
|
| Nestle HealthCare Nutrition | Zenpep | $179 | 11 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $157 | 8 payments
|
| Daiichi Sankyo | Injectafer | $124 | 7 payments
|
| Ironwood Pharmaceuticals | Linzess | $120 | 9 payments
|
| Merck Sharp & Dohme | Dificid | $90 | 4 payments
|
| Braintree Laboratories | Sutab | $49 | 2 payments
|
| Celgene | Zeposia | $36 | 2 payments
|
| RedHill Biopharma | Aemcolo | $27 | 1 payment
|
| Alfasigma USA | Zelnorm | $24 | 1 payment
|
| Boston Scientific | General Hemostasis | $15 | 1 payment
|
2020: $1,631
| Gilead Sciences | None | $401 | 23 payments
|
| AbbVie | Creon | $337 | 20 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $333 | 18 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $144 | 8 payments
|
| Ironwood Pharmaceuticals | Linzess | $124 | 10 payments
|
| Daiichi Sankyo | Injectafer | $98 | 5 payments
|
| Intercept Pharmaceuticals | Ocaliva | $74 | 3 payments
|
| RedHill Biopharma | Aemcolo | $54 | 2 payments
|
| Allergan | Zenpep | $42 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $17 | 1 payment
|
| Ambu | None | $9 | 1 payment
|
2019: $1,827
| Gilead Sciences | Vemlidy | $343 | 16 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $288 | 16 payments
|
| AbbVie | Mavyret | $278 | 19 payments
|
| Allergan | Zenpep | $256 | 25 payments
|
| Ferring Pharmaceuticals | Clenpiq | $86 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $72 | 6 payments
|
| Ironwood Pharmaceuticals | Linzess | $72 | 4 payments
|
| Daiichi Sankyo | Injectafer | $72 | 3 payments
|
| Intercept Pharmaceuticals | Ocaliva | $61 | 3 payments
|
| Shionogi | Mulpleta | $51 | 3 payments
|
| Braintree Laboratories | Motofen | $49 | 3 payments
|
| Merck Sharp & Dohme | Dificid | $46 | 3 payments
|
| Janssen Biotech | Stelara | $44 | 2 payments
|
| Pfizer | Inflectra | $39 | 2 payments
|
| QOL Medical | Sucraid | $23 | 2 payments
|
| Shire North American Group | Gattex | $21 | 1 payment
|
| Concordia Pharmaceuticals | Donnatal | $12 | 1 payment
|
| Napo Pharmaceuticals | Mytesi | $12 | 1 payment
|
Checkups this office reported
2 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 94%That's most of the people this applied to. | 492 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 96%That's most of the people this applied to. | 679 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Chronic Care and Preventative Care Management for Empaneled Patients
- Did a security review of patient data
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of formal quality improvement methods, practice changes, or other practice improvement processes
- Implementation of medication management practice improvements
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Use of QCDR data for ongoing practice assessment and improvements
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1891794152
- Licence
- CA G83120California G83120: Current · expires 2028-05-31
- Trained
- Columbia University College of Physicians and Surgeons, 1993 · 33 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0092050
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1850 Sullivan Ave, #520, Daly City, CA, 94015
- NPI first listed
- 2005-07-19
- NPI last updated
- 2014-09-10
This is when the NPI record was last certified, not a medical board exam.